Related by context. All words. (Click for frequent words.) 74 ASH Annual Meeting 73 Annual ICAAC 71 AACR #st Annual Meeting 71 Annual Transcatheter Cardiovascular 70 Biological Therapy 70 Gastrointestinal Cancers Symposium 70 Hematology Annual Meeting 70 nd Annual Meeting 70 Cancer Therapeutic 69 Cancer iSBTc 69 ASMS Conference 69 Therapeutics TCT 68 #st Annual Meeting 67 Oral Presentations 67 Preclinical Data 67 #nd Annual Meeting 67 AASLD Meeting 67 Therapeutics TCT scientific 67 Molecular Medicine Tri 67 Preclinical Study 67 ASTRO Annual Meeting 67 Cancers Symposium 67 EORTC NCI AACR Symposium 67 ASCO Annual Meeting 66 Hematology ASH Annual Meeting 66 Annual Scientific Sessions 66 ASM Biodefense 66 Endocrine Society Annual Meeting 66 AAEP Convention 66 Hematology Meeting 66 Prostate Cancer Symposium 66 AACR Annual Meeting 66 Kinase Inhibitor 65 Cambridge Healthtech Institute 65 Drug Formulation 65 Clinical Trial Results 65 Breast Cancer Symposium 65 Microbiology ASM 65 Targeted Therapies 65 ISPOR 65 AACR NCI EORTC 65 Endocrine Society ENDO 65 Inflammatory Arthritis 65 Symposium SABCS 65 Genitourinary Cancers Symposium 64 Dendritic Cells 64 ASCO GI 64 RNAi Therapeutic 64 ICAAC IDSA 64 Anti Angiogenesis 64 Late Breaker 64 Malignant Lymphoma 64 Anti Tumor 64 ABRF 64 Antibody Engineering 64 Antibody Therapeutics 64 Novel Therapeutics 64 Clinical Oncology Annual Meeting 64 Inflammatory Disease 64 Hematological Malignancies 64 Anti Tumor Activity 64 AABB Annual Meeting 64 Kinase Inhibitors 64 Autoimmunity 64 Cardiovascular Therapeutics 64 annual Transcatheter Cardiovascular 64 ECCMID 63 Oncolytic Viruses 63 ICAAC 63 Therapeutic Targets 63 ASGT 63 Drug Candidate 63 AACR San Antonio 63 Biologic Therapy 63 Anticancer Drugs 63 Presents Preclinical Data 63 Postdoctoral Position 63 BIOCOM Investor Conference 63 Novel Oral 63 Related Disorders ICAD 63 AUA Annual Meeting 63 Oral Fingolimod 63 Poster Presentations 63 Poster Discussion 63 Prolongs Survival 63 Vascular Annual Meeting 63 Phase 2b Clinical Trial 63 Autoimmune Diseases 63 Nephrology Renal Week 63 Therapeutic Radiation 63 Double Blind Placebo 63 Completes Patient Enrollment 63 Rheumatology ACR Annual 63 Small Molecule 63 #nd EORTC NCI 62 Tyrosine Kinase Inhibitor 62 Tumor Microenvironment 62 SPIE Photonics West 62 Announces Presentation 62 International Myeloma Workshop 62 Selective Cardiac Myosin 62 Female Urology 62 Immunomedics Announces 62 Therapeutic Vaccines 62 Phase 2a Trial 62 ACR ARHP 62 Opportunistic Infections CROI 62 Applied Spectroscopy 62 Anticancer Drug 62 Chemotherapy ICAAC 62 Largest Database 62 Tezampanel 62 Cell Transplant 62 Poster Presentation 62 Successfully Completes Phase 62 Gene Therapy ASGT 62 Antiviral Research 62 Files IND 62 entitled Synergistic 62 Shows Promising 62 CTRC AACR San Antonio 62 Issued Patent 62 Oncology ASTRO 62 Therapeutic Potential 62 Systemic Delivery 62 DIA Annual Meeting 62 EORTC NCI AACR 61 Molecular Diagnostic 61 HCV Protease Inhibitor 61 Protein Therapeutics 61 Digestive Disease Week DDW 61 GTCbio 61 EORTC NCI 61 ACR ARHP Annual 61 Hsp# Inhibitor 61 ASCO GU 61 HFSA Annual 61 Novel Therapeutic 61 Receives Orphan Drug Designation 61 Present Preclinical Data 61 Therapeutic Antibodies 61 Novel Inhibitor 61 Announces Poster Presentations 61 Initiates Clinical Trial 61 Gynecologic Cancer Society 61 Annual Interscience Conference 61 Autoimmune Disease 61 Combination REOLYSIN R 61 Pooled Analysis 61 Novel Antibody 61 Spine Arthroplasty Society 61 Metabolic Disease 61 Vitro Activity 61 DNA Methylation 61 Abstract Number 61 ADA Scientific Sessions 61 Molecular Mechanisms 61 Clinical Trial Data 61 Oral Presentation 61 Targeted Anticancer Therapies 61 Oligonucleotides 61 Postgraduate Course 61 Nicotine Vaccine 61 Initiates Clinical 61 Collaborators Present 61 Cancer Stem Cells 61 AHA Scientific Sessions 61 Anti CD# Antibody 61 Phase Ib Clinical Trial 61 Inflammatory Diseases 61 Preclinical Models 61 AAO HNSF Annual Meeting 61 AACR IASLC Joint 61 Phase IIb Clinical Trial 61 VentiRx Pharmaceuticals 61 Digestive Diseases Week 61 Investigational Drug 61 Clinical Outcome 61 Connective Tissue Oncology 61 Randomized Phase III 61 Peer Reviewed Publication 61 Metastatic Melanoma 61 Experimental Hematology 61 Aptamer 61 Novel Treatments 61 Mouse Model 61 CLEO QELS 61 AAPS Annual Meeting 61 Protein Interaction 61 Chronic Lymphocytic Leukemia 61 NSTI Nanotech 60 Vaccine Adjuvant 60 ASCO Breast Cancer 60 UEGW 60 Midyear Clinical Meeting 60 Thermo Scientific booth 60 Gastroenterology ACG Annual 60 Beneficial Effects 60 Presents Positive 60 Molecular Markers 60 Proteasome 60 Trodusquemine MSI 60 Hematologic Malignancies 60 Cancer Immunotherapy 60 Interferon Gamma 60 Clinical Oncology ASCO Annual 60 Abstract Accepted 60 Haemostasis ISTH 60 Reports Preclinical Data 60 Therapeutic Radiation Oncology 60 ERA EDTA 60 Patient Treated 60 Oligonucleotide Therapeutics Society 60 lexidronam injection 60 Biodefense Vaccines 60 Neoplasia 60 Oncology ESTRO 60 First Patient Enrolled 60 Cardiovascular Disease Epidemiology 60 Protein Expression 60 Refractory Angina 60 Phase 2b Trial 60 Sangamo BioSciences Announces 60 Meets Primary Endpoint 60 Anticancer Activity 60 Innate Immunity 60 Preclinical Evaluation 60 Novel Antibiotic 60 Collaborators Publish 60 Antitumor Activity 60 Antithrombotic 60 Cancer Vaccines 60 Clinical Trials Update 60 Non Invasive Treatment 60 Podium Presentation 60 Chronic Lymphocytic Leukemia CLL 60 Delcath Phase III 60 Single Molecule 60 Clinical Virology Symposium 60 HDAC Inhibitor 60 Acute Heart Failure 60 Advanced Renal Cell 60 Oligonucleotide 60 Patent Issued 60 Association EHA 60 Drug Shows Promise 60 Antimicrobial Agents 60 AACR #nd Annual Meeting 60 Neurology Annual Meeting 60 Preclinical Studies 60 Gynecologic Investigation 60 Breast Cancer Symposium SABCS 60 Keystone Symposia 60 See CLINICAL PHARMACOLOGY 60 Hematology Molecular Pathology 60 PROSTASCINT R 60 Transcatheter Cardiovascular Therapeutics TCT 60 Preclinical Efficacy 60 Immunology Annual Meeting 60 RNAi Therapeutics 60 Cancer Therapies 60 Neuro Oncology SNO 60 Interventional Oncology 60 Keystone Symposium 59 abstr 59 Investigational Treatment 59 Treating Chronic 59 Lung Cancer Drug 59 Patient Enrollment 59 SABCS 59 Hematological Cancers 59 Initiates Enrollment 59 Mass Spectrometry ASMS 59 Randomized Double blind 59 Recurrent Breast Cancer 59 Valopicitabine 59 Completes Enrollment 59 Monoclonal Antibodies 59 IND Filing 59 Atrial Fibrillation Symposium 59 Mimetics 59 Epitope 59 Hormone Refractory Prostate Cancer 59 Novel Mechanism 59 SMi 59 Gastric Cancer 59 Protein Involved 59 Renal Cancer 59 Receives Orphan Drug 59 GTCbio 3rd 59 Shows Promise Against 59 Develops Novel 59 Ocular Inflammation 59 Poster Session 59 Antiviral Therapy 59 Phase III Trial 59 Randomized Phase 59 Randomized Controlled 59 Biomarker Study 59 Initiates Phase II 59 Phase 2a Clinical Trial 59 Safety Tolerability 59 Anthrax Toxin 59 Mouse Models 59 Helps Predict 59 & OTO EXPO 59 Viral Infections 59 Environ Health Perspect 59 J.P. Morgan Healthcare 59 Systemic Sclerosis 59 AHIMA Convention 59 Endocrine Society #nd 59 Needham Biotechnology 59 Molecular Mechanism 59 Modulates 59 Protein Biomarker 59 Image Guided 59 Cytotoxicity 59 Adult Stem Cell Therapy 59 Endocrine Society #st 59 Novel Approaches 59 RNA Interference 59 CROI 59 Biophysical Society 59 AACR 59 Therapeutic Approaches 59 Laryngeal Cancer 59 Ocular Pharmacology 59 ECTRIMS 59 Metabolic Disorders 59 #:#-# [033] 59 Vascular Targeting Agents 59 Antibody Drug Conjugate 59 Ion Channels 59 Gene Silencing 59 Neuropharmacology 59 Protein Structure 59 Parathyroid Hormone 59 Osteoporosis Treatment 59 pralatrexate injection folate analogue 59 Patient Enrolment 59 Brentuximab Vedotin SGN 59 Histocompatibility 59 Gastrointestinal Oncology 59 Investigational Compound 59 Extracellular Matrix 59 Cytometry 59 Significantly Improves 59 Recombinant Protein 59 Lung Cancer Trial 59 EULAR Annual 59 Protease Inhibitor 59 Small Fuel Cells 59 Anti Angiogenic 59 Heska Announces 59 Controlled Release 59 Metabolic Endocrinology 59 Microanalysis 59 siRNA Delivery 59 Rheumatology Annual 59 C# BioVentures 59 Monoclonal Antibody 59 Adjuvant Chemotherapy 59 Vaccine Adjuvants 59 Molecular Targets 59 AACR Frontiers 59 Sipuleucel T 59 Signaling Pathways 59 AAAAI Annual Meeting 59 Announces FDA Clearance 59 Experts Convene 59 Synthetic Chemistry 59 Gastrointestinal Cancer 59 Male Infertility 59 Arteriosclerosis Thrombosis 59 Talabostat 59 Exhibitor Profiles 59 Proves Effective 59 Blood Cancers 59 Vascular Biology ATVB 59 IND Application 58 Inflammatory Markers 58 Immune Cell 58 Novel Protein 58 Randomized Study 58 Monoclonal 58 Contrast Agents 58 Exhibitor Profile 58 Lupus Nephritis 58 Immunodeficiencies 58 Dose Response 58 Fungal Infections 58 Clinical Oncology Gastrointestinal Cancers 58 pan HDAC inhibitor 58 EastGroup Properties Announces 58 Clinical Dermatology 58 Molecular Origins 58 BIO InvestorForum 58 Prognostic Value 58 Advanced Melanoma 58 Solid Tumors 58 Demonstrates Efficacy 58 Guidelines Recommend 58 Demonstrates Potential 58 Safinamide 58 Autologous Stem Cell Transplantation 58 Islet Transplantation 58 Phase III Clinical Trial 58 Study Evaluating 58 Hepatitis C Infection 58 RTECC 58 Angiogenic 58 Molecular Basis 58 Gastrointestinal Disorders 58 Develop Novel 58 Therapeutic Antibody 58 Completes Dosing 58 BiTE Antibody 58 Genetic Basis 58 J Clin 58 Recombinant Human 58 FDA Okays 58 ASBMR 58 Biocomputing 58 J Clin Endocrinol Metab 58 Novel Therapies 58 #:#-#,# [003] 58 www.bio.org 58 Gene Linked 58 Progenitor Cells 58 Minimally Invasive Spine Surgery 58 Myelodysplastic Syndromes 58 Relapsing Multiple Sclerosis 58 Awarded Patents 58 Regenerative Cells 58 Liver Metastases 58 Oncologic 58 GVAX ® 58 Phase IIb Trial 58 Pathogen Detection 58 Neurodegenerative Disease 58 Commences Phase 58 Vascular Targeting 58 Gene Expression Analysis 58 #:#-# [007] 58 VEITHsymposium 58 Protein Kinase 58 Anti Inflammatory Drug 58 Molecular Cancer 58 Epidermal Growth Factor Receptor 58 Improved Survival 58 Presents Positive Preclinical 58 Neoadjuvant Chemotherapy 58 Lab Automation 58 Malignant Melanoma 58 Diabetic Neuropathy 58 Test Detects 58 Alzheimer Disease ICAD 58 Randomized Double Blind 58 FASEB J. 58 Electrochemical Society 58 Vical Incorporated 58 Phase 1b Clinical Trial 58 JAK2 Inhibitor 58 Nymox NX 58 Canaccord Genuity Growth 58 CCX# 58 st Annual Meeting 58 Cellular Therapy ISCT 58 Anesthesiologists Annual Meeting 58 Receives Milestone Payment 58 Transcription Factor 58 Hormone Receptor Positive 58 Aplidin R 58 Pharmaceutical Scientists AAPS 58 Proc Am Soc 58 Antisense 58 Upcoming Conferences 58 Coronary Revascularization 58 Tissue Engineered 58 Innate Immune 58 Digestive Disease Week 58 Antisense Drug 58 Ceflatonin R 58 Vevo LAZR system 58 Granted Orphan Drug 58 Nerve Regeneration 58 Lung Tumors 58 BioCentury Future Leaders 58 Canaccord Adams Hepatitis C 58 IEEE Photovoltaic Specialists 58 Hematological 58 Photovoltaics Summit 58 Semafore Pharmaceuticals 58 Hematology ASH Meeting 58 Combination Treatment 58 Keynote Lineup 58 Individualized Therapy 58 IMS# 58 Successfully Treated 58 Antiviral Activity 58 Migraine Drug 58 ARVO 58 Bladder Cancer 58 High Throughput Sequencing 58 Brain Metastases 58 Announce Collaboration Agreement 58 Two Upcoming Investor 58 Mesothelioma Treatment 58 Renal Cell Carcinoma 58 Initiates Phase III 58 Peer Reviewed Journal 58 BioProcess International 58 Pulmonary Arterial Hypertension 58 Antigens 58 AACR symposium 58 Maven Semantic 58 Crit Rev 57 Cardiotoxicity 57 antibody blinatumomab MT#/MEDI-# 57 Files Investigational 57 Pemphigus Vulgaris 57 Opportunistic Infections 57 Carfilzomib 57 Metabolic Disorder 57 Tumor Targeting 57 Novel Vaccine 57 Targeted Therapy 57 Tumor Suppressor 57 Biodetection Technologies 57 Demonstrates Significant 57 First Patient Dosed 57 Astralis Ltd. 57 #th Interscience Conference 57 Licenses Novel 57 Orally Active 57 AnaSpec Introduces 57 Presents Preclinical 57 Scientific Sessions 57 LD Micro 57 Enrolling Patients 57 Controlled Trial 57 #:#-# [010] 57 Anesthesiologists ASA Annual Meeting 57 Epitopes 57 Psychiatric Services #:#-#,# 57 Tumor Progression 57 Phase 2b Study 57 Advanced Pancreatic Cancer 57 Insulin Resistance 57 Multicenter Randomized 57 Cardiovascular Disease Risk 57 Consecutive Profitable Quarter 57 Hepatocellular 57 Patients Enrolled 57 Dose Ranging Study 57 Cylene Pharmaceuticals 57 Synthetic Peptide 57 Immunosuppression 57 Protein Kinases 57 Dose Escalation 57 TXPO 57 TenFold Announces 57 Liver Tumors 57 fosbretabulin 57 Artificial Organs 57 SOUTHWESTERN SHOWCASE Investor 57 ALN TTR 57 Immunodiagnostics 57 oral proteasome inhibitor 57 Treated Patients 57 transthyretin TTR mediated amyloidosis 57 Clinical Evaluation 57 Chicago Multidisciplinary Symposium 57 Society CTOS 57 Breast Brachytherapy 57 Bone Metastases 57 Annual AIFA 57 Randomized Trials 57 Adjunctive Therapy 57 SYN# 57 Initiate Phase III 57 Eye Diseases 57 Genes Involved 57 Nereus Pharmaceuticals 57 DermTech International 57 Movement Disorder 57 EMBO J. 57 Protein Synthesis 57 Phase 2a Study 57 Radiation Induced 57 Placebo Controlled Study 57 Macrophage 57 FDA Approves Drug 57 Cognitive Disorders 57 Rigel R# 57 Ichor Medical Systems 57 Physiology Seminar 57 Tesetaxel 57 Bone Grafting 57 Crystallographic 57 Improves Outcomes 57 Ovarian Cancer Treatment 57 Smooth Muscle 57 NOVAVAX 57 Oncogene 57 Breast Cancer Recurrence 57 Whole Genome Sequencing 57 Magnetic Nanoparticles 57 Slows Progression 57 Dose Ranging 57 Cinacalcet 57 Breast Surgeons 57 Centers NCBC 57 Treatment Reduces 57 LabAutomation 57 Deforolimus 57 II Clinical Trial 57 Selective Cardiac Myosin Activator 57 Molecular Evolution 57 Fallopian Tube 57 Inflammatory Bowel Diseases 57 Signaling Pathway 57 Topline Results 57 Urodynamics 57 Suppl. 57 Phase III AFFIRM 57 Webcast Discussion 57 Universal Flu Vaccine 57 Oral Microbiology 57 Cystic Fibrosis Conference NACFC 57 Nucleic Acids 57 Controlled Study 57 Immunogenicity 57 Prenatal Diagnosis 57 Lung Cancers 57 SCAI Annual 57 ASCO Abstract 57 Pivotal Study 57 Immune Responses 57 Pandemic Influenza Vaccines 57 HDL Selective Delipidation 57 Immune Mediated 57 Beta Amyloid 57 Functional Proteomics 57 Potent Anti 57 Susceptibility Gene 57 #:# -# [005] 57 Single Molecules 57 Ocular Diseases 57 European CanCer Organisation ECCO 57 Mass Spectrometry 57 Infectious Diseases ECCMID 57 Chronic Rhinosinusitis 57 ASGCT 57 Investigational Agent 57 Potent Inhibitor 57 Cell Biology ASCB 57 ExL Pharma 57 Radiation Oncology ASTRO 57 Cardiostim 57 Medical Oncology ESMO 57 Speakers Announced 57 Arch Neurol 57 Phase III Clinical Trials 57 Windhover Therapeutic Area 57 Initiates Dosing 57 Experimental Vaccine 57 International Papillomavirus 57 Inflammatory Response 57 AACC Annual Meeting 57 Biodesix 57 ST Elevation Myocardial 57 Bacterial Cell 57 Placebo Controlled Trial 57 Molecular Biomarkers 57 Pharmacokinetic Study 57 Cell Adhesion 57 Taglich Brothers Initiates Coverage 57 MTT S 57 ERA D2C Convention 57 MorphoSys AG FSE MOR 57 Ann Rheum Dis 57 Neural Stem Cell 57 Therapeutic Radiology 57 Nanoemulsion 57 Anti Inflammatory Drugs 57 Initiates Clinical Trials 57 Effectively Treats 57 Clinical Oncology ASCO Gastrointestinal 57 Influenza Vaccine Production 57 Epeius Biotechnologies Corporation 57 Polymerase Inhibitor 57 Endocrinol 57 Immunotherapeutic 57 Preterm Labor 56 Psoriasis Drug 56 depsipeptide 56 DoDIIS Worldwide Conference 56 Sapacitabine 56 Antigen Specific 56 Allosteric 56 Soft Tissue Sarcoma 56 Lumbar Spine 56 ThinkEquity Growth 56 HIV Integrase 56 Oral Insulin 56 Am J Pathol 56 Gene Mutation 56 Receives CE Marking 56 Vertebral Fractures 56 Islet Transplant 56 Anticancer Agent 56 Bionanotechnology 56 Breast Ultrasound 56 WLSA Convergence Summit 56 Transdermal Delivery 56 IASLC 56 Pharmacogenomic 56 Pediatric Oncology Branch 56 Diabetic Foot Ulcer 56 Glufosfamide 56 ANN INTERN MED 56 Imaging Techniques 56 Immunomodulatory 56 Cell Signalling 56 Study Demonstrates 56 #-# Full Text 56 Am J Epidemiol 56 Well Tolerated 56 Metabolomics 56 Molecular Diagnostic Test 56 Metastatic Renal Cell Carcinoma 56 Transcriptome 56 Oral Calcitonin 56 Tuberculosis Vaccine 56 International OARSI 56 ESTRO 56 Gets FDA Clearance 56 Cell Differentiation 56 Polymorphism 56 Cardiomyocytes 56 Severe Sepsis 56 Inc. Nasdaq IMGN 56 IEEE MTT S 56 Disease Modifying 56 ENDO 56 Diabetic Nephropathy 56 Taglich Brothers Small Cap 56 Patients Treated With 56 Epithelium 56 VIVUS Qnexa 56 Serious Infections 56 BiOS 56 Demonstrates Ability 56 Technological Advances 56 Phase III Trials 56 Bazedoxifene 56 Prospective Randomized 56 Lung Cancer IASLC 56 Randomized Phase II 56 Stent Thrombosis 56 Previously Treated 56 #th Annual Interscience 56 Lupus Drug 56 AAN Annual Meeting 56 Outcome Sciences 56 Liver Meeting 56 Ovarian Cancer Patients 56 Retrovirus 56 Aggressive Reduction 56 Surgical Mesh 56 AVI BioPharma Announces 56 GITA Annual 56 Webcast Presentations 56 OBBeC 56 Biopharmaceutical Manufacturing 56 Gynecological Cancers 56 Acute Treatment 56 Protein Protein Interactions 56 Annual Meeting 56 Am J Geriatr 56 #:# -# [003] 56 Orphan Diseases 56 Inhaled Liposomal Ciprofloxacin 56 Clinical Microbiology 56 Analytical Methods 56 Neuroprotection 56 Milestone Payment 56 Upcoming Investor 56 Laser Ablation 56 Shows Promise 56 Amniotic Fluid 56 Zinc Finger Nuclease 56 Gynecol Oncol 56 Twentieth Annual 56 Cannabinoid 56 Breast Tissue 56 Patent Covering 56 Treatment Regimen 56 DDW ® 56 Hepatocellular Carcinoma 56 Photochemistry 56 Predict Risk 56 Annual LD MICRO 56 Molecular Spectroscopy 56 Hepatitis C Treatment 56 www.aacr.org 56 Stem Cell Treatment 56 Pulmonary Hypertension 56 Small Molecules 56 Upcoming Milestones 56 Reliability Physics 56 Meta Analysis 56 SCTE Cable Tec EXPO 56 Neurology AAN Annual Meeting 56 Announces Rescheduling 56 Vulnerable Plaque 56 Histone Deacetylase 56 Survival Benefit 56 Aurora Kinase 56 Antiangiogenic 56 Trial Evaluating 56 Initiate Phase 56 Announce License Agreement 56 HDL Mimetic Peptide 56 Diagnostic Tests 56 Neuroendocrinology 56 Pulmonary Vein Isolation 56 Mammalian Cells 56 Protein Linked 56 Shows Efficacy 56 Submission Deadline 56 Preclinical Testing 56 non nucleoside inhibitor 56 Human Genetics ASHG 56 #:# -# [004] 56 Genes Identified 56 Anticancer Agents 56 Cardiac Rhythm 56 Announce Merger Agreement 56 Electro Optics CLEO 56 Pivotal Phase III 56 Mechanistic 56 Submits NDA 56 Kidney Transplant Recipients 56 Porous Materials 56 MEK Inhibitor 56 #:#-#,# CrossRef Medline [002] 56 Biologics Manufacturing 56 Malignant Mesothelioma 56 Autoimmune Disorders 56 Aflibercept 56 Slow Progression 56 Renal Cell Cancer 56 C# BioVentures Conference 56 AAAS Annual Meeting 56 MassGeneral Institute 56 Severe Asthma 56 www.asco.org 56 Treatment Approaches 56 Multiple Myeloma Patients 56 Minimally Invasive Treatment 56 Nephrol 56 Completes Patient Enrolment 56 Biomarker Discovery 56 ASCO Gastrointestinal Cancers Symposium 56 Endoscopic Surgeons SAGES 56 www.pranabio.com 56 Gamma Imaging BSGI 56 Salivary 56 MedChem 56 Immunochemistry 56 Flexible Electronics 56 Elagolix 56 Phenotyping 56 Improves Survival 56 Multiple Sclerosis ECTRIMS 56 Mitral Valve Repair 56 Proven Effective 56 Transdermal Patch 56 PET Scanner 56 REMINDER ORLive Presents 56 Nephrology Annual Meeting 56 Cites Positive 56 Clinical Trial Evaluating 56 Develop Innovative 56 Allograft 56 Particle Characterization 56 Randomized Controlled Trials 56 Pivotal Phase 56 HER2 Positive 56 Helps Diagnose 56 Lysosomal 56 Demonstrates Positive 56 Noninvasive Prenatal 56 Whole Genome 56 Cardiac Stem Cell 56 Genetic Variation 56 Improve Survival 56 ISTH 56 Ophthalmol 56 Thrombolytic Therapy 56 Therapeutic Competitors Companies 56 Annual Canaccord Genuity 56 Transcatheter Cardiovascular Therapeutics 56 Liver EASL 56 Gene Variation 56 Genetic Disorders 56 Endourology 55 Interventional Radiology SIR 55 Novel Method 55 CSCMP Annual Conference 55 Novel Small Molecule 55 Anticancer Compound 55 Neuropathic Pain 55 J Natl Cancer Inst 55 Osteoporosis Drug 55 Medicine ISMRM 55 Diabetes Complications 55 Inherited Diseases 55 FDA Clears 55 Macromolecules 55 Locked Nucleic Acid 55 Ovarian Cancers 55 Inhibits 55 Holds Promise 55 EFORT Congress 55 Arch sts 55 Prospective Multicenter 55 Related Viruses 55 Demonstrates Sustained 55 Vaccine Protects Against 55 Announces Keynote Speaker 55 J Nutr 55 Malignancies 55 Therapeutic Efficacy 55 Advanced Neuroendocrine Tumors 55 Intracranial Aneurysms 55 Unither 55 Pediatric Academic Societies 55 Transdermal Drug 55 cMET 55 Heart Failure Patients 55 ThermoDox ® clinical 55 Webinar Focuses 55 BioElectronics Corporation Announces 55 Cancer Therapeutics 55 Heart Failure Treatment 55 Ocular Disease 55 Reduced Risk 55 Mucosal 55 Hyperlipidemia 55 Stem Cell Differentiation 55 Therapeutics Roundtable 55 Therapeutic Vaccine 55 Immune Cells 55 Heart Transplant Recipients 55 Complete Remission 55 Multiple Sclerosis Rheumatoid Arthritis 55 Plaque Psoriasis 55 Annual Westergaard SmallCap 55 Achieves Milestone 55 Contrast Agent 55 #:#-# [006] 55 First Patient Treated 55 FDA Approvals 55 Solid Malignancies 55 Multicenter Trial 55 Advanced Colorectal Cancer 55 Potent Antiviral Activity 55 #rd Annual CTRC 55 Oral Mucositis 55 Neuromuscular Diseases 55 Study Validates 55 WorldHeart Announces 55 Antithrombin 55 Cervical Dysplasia 55 PITTCON 55 sorafenib tablets 55 Erectile Dysfunction Drug 55 Interferon Beta 55 Macromolecular 55 Anti Infective 55 Hedgehog Pathway 55 ECNP Congress 55 Parathyroid 55 Pivotal Trial 55 Parkinson Diseases 55 Phase III Pivotal 55 selective kinase inhibitor 55 Endoscopic Surgery 55 Clinical Efficacy 55 Focal Therapy 55 Surgery Performed 55 EDSFair 55 Chronic Hepatitis C 55 Scientific Meeting 55 Cartilage Repair